FOLFIRINOX is a chemotherapy regimen for treatment of advanced pancreatic cancer. It is made up of the following four drugs: FOL – folinic acid (leucovorin)...
7 KB (716 words) - 18:09, 29 August 2024
dissimilar to FOLFIRINOX. Upfront FOLFOXIRI with bevacizumab can be followed by fluoropyrimidine with bevacizumab maintenance. FOLFIRI FOLFOX FOLFIRINOX IFL Nipp...
5 KB (574 words) - 21:05, 6 May 2024
evaluate efficacy and safety of devimistat plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas...
4 KB (240 words) - 20:44, 7 July 2024
pancreatic cancer as a less toxic (although less effective) alternative to FOLFIRINOX. Abraxane is registered on the Australian Register of Therapeutic Goods...
9 KB (716 words) - 09:40, 4 August 2024
needed] of irinotecan may lead to neutropenia. Dose-dense chemotherapy FOLFIRINOX FOLFOX FOLFOXIRI IFL Chen, K; Gong, Y; Zhang, Q; Shen, Y; Zhou, T (2016)...
4 KB (411 words) - 21:05, 6 May 2024
surgical resection. As of 2018[update], when chemotherapy is given the FOLFIRINOX regimen containing fluorouracil, irinotecan, oxaliplatin and leucovorin...
50 KB (5,610 words) - 14:40, 4 August 2024
Patient's ability to conceive offspring may be affected by treatment. FOLFIRI FOLFIRINOX IFL "FOLFOX". Cancer Research UK. Archived from the original on 12 April...
10 KB (1,337 words) - 04:46, 21 April 2023
erlotinib was licensed by the FDA for use in pancreatic cancer in 2005. The FOLFIRINOX chemotherapy regimen using four drugs was found more effective than gemcitabine...
122 KB (12,761 words) - 07:50, 12 September 2024
fluorouracil (5-FU), leucovorin (folinic acid), irinotecan colorectal cancer FOLFIRINOX fluorouracil (5-FU), leucovorin (folinic acid), irinotecan, oxaliplatin...
23 KB (634 words) - 23:47, 16 August 2024
as an infusion over 48 hours. Dose-dense chemotherapy FOLFIRI FOLFOX FOLFIRINOX Chen, K; Gong, Y; Zhang, Q; Shen, Y; Zhou, T (2016). "Efficacy and safety...
1 KB (109 words) - 10:15, 18 October 2021
Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment". {{cite journal}}: Cite journal requires |journal= (help) Thau...
15 KB (1,731 words) - 12:34, 29 August 2023
; Zurlo, V.; Basso, M.; Cassano, A. (2016-10-01). "Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything...
6 KB (635 words) - 12:33, 24 January 2024
of IRE compared with standard-of care chemotherapeutic treatment with FOLFIRINOX (a combination of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin)...
74 KB (7,906 words) - 17:42, 8 September 2024
tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label...
23 KB (2,522 words) - 12:00, 30 July 2024
Oncology; protein-bound paclitaxel (Abraxane), marketed by Celgene; and FOLFIRINOX, which is a combination of generic products that are sold individually...
60 KB (3,820 words) - 13:49, 14 September 2024